These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1690747

  • 1. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Lindner J, Rivier JE, Vale WW, Pavlou SN.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1219-24. PubMed ID: 1690747
    [Abstract] [Full Text] [Related]

  • 2. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, Stallard DJ.
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [Abstract] [Full Text] [Related]

  • 3. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN, Wakefield G, Schlechter NL, Lindner J, Souza KH, Kamilaris TC, Konidaris S, Rivier JE, Vale WW, Toglia M.
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
    Hall JE, Whitcomb RW, Rivier JE, Vale WW, Crowley WF.
    J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
    [Abstract] [Full Text] [Related]

  • 5. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
    Andreyko JL, Monroe SE, Marshall LA, Fluker MR, Nerenberg CA, Jaffe RB.
    J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
    [Abstract] [Full Text] [Related]

  • 6. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
    Dubourdieu S, Charbonnel B, D'Acremont MF, Carreau S, Spitz IM, Bouchard P.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
    [Abstract] [Full Text] [Related]

  • 7. Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effect of sex steroid replacement.
    Perheentupa A, Huhtaniemi I.
    Endocrinology; 1990 Jun; 126(6):3204-9. PubMed ID: 1693570
    [Abstract] [Full Text] [Related]

  • 8. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L, Bhasin S, Salameh W, Steiner B, Peterson M, Sokol RZ, Rivier J, Vale W, Swerdloff RS.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [Abstract] [Full Text] [Related]

  • 9. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH, Goldstein M, Kourides IA, Comite F, Bardin CW, Krieger DT.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [Abstract] [Full Text] [Related]

  • 10. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
    McLachlan RI, Cohen NL, Vale WW, Rivier JE, Burger HG, Bremner WJ, Soules MR.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
    [Abstract] [Full Text] [Related]

  • 11. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A, Jameson JL, Biller BM, Crowley WF, Zervas NT, Rivier J, Vale WW, Bikkal H.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys.
    Burgos-Briceño LA, Schally AV, Bartke A, Asch RH.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248
    [Abstract] [Full Text] [Related]

  • 13. Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women.
    Couzinet B, Lahlou N, Thomas G, Thalabard JC, Bouchard P, Roger M, Schaison G.
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):477-83. PubMed ID: 1716186
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men.
    Bagatell CJ, McLachlan RI, de Kretser DM, Burger HG, Vale WW, Rivier JE, Bremner WJ.
    J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592
    [Abstract] [Full Text] [Related]

  • 15. Gonadotropin and alpha-subunit secretion during long term pituitary suppression by D-Trp6-luteinizing hormone-releasing hormone microcapsules as treatment of precocious puberty.
    Lahlou N, Roger M, Chaussain JL, Feinstein MC, Sultan C, Toublanc JE, Schally AV, Scholler R.
    J Clin Endocrinol Metab; 1987 Nov; 65(5):946-53. PubMed ID: 2959680
    [Abstract] [Full Text] [Related]

  • 16. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN, Wakefield GB, Island DP, Hoffman PG, LePage ME, Chan RL, Nerenberg CA, Kovacs WJ.
    J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388
    [Abstract] [Full Text] [Related]

  • 17. Gonadotropin-releasing hormone-dependent regulation of gonadotropin subunit messenger ribonucleic acid levels in the rat.
    Wierman ME, Rivier JE, Wang C.
    Endocrinology; 1989 Jan; 124(1):272-8. PubMed ID: 2491805
    [Abstract] [Full Text] [Related]

  • 18. Effects of testosterone on gonadotropin subunit messenger ribonucleic acids in the presence or absence of gonadotropin-releasing hormone.
    Winters SJ, Ishizaka K, Kitahara S, Troen P, Attardi B.
    Endocrinology; 1992 Feb; 130(2):726-34. PubMed ID: 1370794
    [Abstract] [Full Text] [Related]

  • 19. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
    Salameh W, Bhasin S, Steiner B, McAdams LA, Peterson M, Swerdloff R.
    Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888
    [Abstract] [Full Text] [Related]

  • 20. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN, Brewer K, Farley MG, Lindner J, Bastias MC, Rogers BJ, Swift LL, Rivier JE, Vale WW, Conn PM.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.